LEGAL NOTICE & MEDICAL DISCLAIMER

PeptoSfera

Last updated: 2026-07-01

PeptoSfera is operated from Brazil under Brazilian law. The Portuguese version at peptosfera.com.br/aviso-legal is the governing document; this English translation is for convenience.

PeptoSfera is an independent editorial publication about peptides, biohacking, GLP-1s and longevity, distributed as an email newsletter and at https://peptosfera.com.br. All content is published for informational, educational and journalistic purposes only.

1. PeptoSfera is not a healthcare service

PeptoSfera is not a medical service, a clinic, a pharmacy, or a supplier of medicines, peptides or supplements. PeptoSfera does not prescribe, does not sell, does not point to sources of purchase, does not dispense medicines, and does not replace medical consultation.

2. Informational content — not medical advice

Content about molecules, doses, cycles, stacks and protocols reflects scientific literature, published clinical studies and reported use — intended for the reader's conceptual understanding.

This content does NOT replace consultation, diagnosis, prescription or treatment by a licensed physician or health professional. Reading PeptoSfera does not create a doctor-patient relationship and does not constitute a recommendation, endorsement or encouragement to use any substance.

No health decision should be made based solely on this publication. Any decision to use is the sole responsibility of the reader and their licensed physician.

3. Substances mentioned and regulation in Brazil (Anvisa)

Several substances mentioned — including, without limitation, BPC-157, TB-500, MOTS-c, GHRH/GHRP peptides and others — are not approved by Anvisa for human use in Brazil.

GLP-1s such as semaglutide and tirzepatide are prescription-only medicines, sold only with a medical prescription subject to retention, under current Anvisa rules (including IN 360/2025 and RDC 973/2025). Off-label use is deemed irregular and dangerous by Anvisa (Alert 02/2026).

Any use of a substance mentioned must be carried out exclusively under the guidance and prescription of a licensed physician. Nothing here constitutes advertising, promotion, demand inducement or manipulation instructions for any substance — consistent with Anvisa's RDC 96/2008 and other rules.

4. Reader acknowledgment

By subscribing to and reading PeptoSfera, you acknowledge that: (1) the content is informational and editorial, not medical; (2) nothing here replaces individualized clinical assessment; (3) any use of a mentioned substance must occur under a physician's guidance and prescription; (4) José Carlos Wender de Brito, editor of PeptoSfera, and any collaborators, are not liable for use decisions, adverse effects or consequences arising from unsupervised application of the content.

If you suspect an adverse effect, seek medical attention immediately.

5. No guaranteed results

Individual results vary significantly. The editor does not guarantee any specific outcome — body composition, recovery, performance, longevity or otherwise — from reading the content. No PeptoSfera content promises weight loss, cure or any defined benefit.

6. AI-assisted content

Some content may be researched, drafted or reviewed with AI tools, always under human editorial curation. Despite accuracy efforts, we do not guarantee content is error-free or current. Readers should verify independently and, above all, with their physician.

7. Adults only (18+)

PeptoSfera is intended exclusively for adults aged 18+. The content covers pharmacological substances and health topics unsuitable for minors and is not directed at children or adolescents (Digital ECA, Law No. 15,211/2025).

8. Limits of this disclaimer (Consumer Protection Code)

Nothing in this Notice excludes or reduces the non-waivable consumer rights under the Brazilian Consumer Protection Code (Law No. 8,078/1990), nor liability for defects in the newsletter service itself.

9. Intellectual property

All PeptoSfera content — text, brand, visual identity and editorial materials — is protected under Brazilian IP law (Law No. 9,610/1998). Reproduction, distribution or republication without prior written authorization is prohibited.

10. Contact

Questions about this Legal Notice: editor@peptosfera.com.br

Editor: José Carlos Wender de Brito (individual) São Paulo · peptosfera.com.br Effective date: 2026-07-01

Verification: Perplexity (current norms) ✓ · ChatGPT GPT-4o review ✓ · Generated 2026-07-01 by Gabriel